Alpine Immune Sciences Inc buy woelli
Summary
This prediction ended on 22.12.16 with a price of €7.32. With a performance of -8.97%, the BUY prediction for Alpine Immune Sciences Inc by woelli closed slightly in the red. woelli has 50% into this predictionAlpine Immune Sciences is a clinical-stage biotechnology company focused on developing novel therapies that modulate the immune system to treat cancer, autoimmune, and inflammatory diseases. The company's proprietary platform technology, called "Variant Ig Domain" (vIgD), enables the design and development of unique protein therapeutics that can target specific immune cells and pathways. Alpine's lead product candidate, ALPN-202, is a dual ICOS/CD28 antagonist for the treatment of autoimmune and inflammatory diseases, and the company has several other product candidates in preclinical development. Alpine Immune Sciences is listed on the NASDAQ stock exchange under the ticker symbol "ALPN".
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alpine Immune Sciences Inc | - | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by woelli for this prediction
In the thread Alpine Immune Sciences Inc diskutieren
woelli stimmt dem Crowdsentiment von 'Buy' zu
woelli stimmt am 13.12.2016 dem Buy-Crowdsentiment mit dem Kursziel 5.0$ zu.
Stopped prediction by woelli for Alpine Immune Sciences Inc
Alpine Immune Sciences Inc
16.03.17
17.04.17
17.04.17